Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

519 results

Timing of intervention in patients with severe tricuspid regurgitation

30 Aug 2023

Alex Sticchi interviews Julien Dreyfus about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam, which suggests that, in patients with severe TR, a curative intervention should be considered at an early stage of the disease as assessed by...

Alessandro Sticchi

Author

Alessandro Sticchi
Julien Dreyfus

Author

Julien Dreyfus
Timing of intervention in patients with severe tricuspid regurgitation

Short-term outcomes of tricuspid edge-to-edge repair in clinical practice – bRIGHT study

12 Jun 2023

The aim of the b-RIGHT study was to assess the safety and performance of T-TEER using the TriClip (Abbott) in a contemporary, real-world setting...

Jonathan Curio

Reviewer

Jonathan Curio
Fabien Praz

Reviewer

Fabien Praz
Mirjam Wild

Reviewer

Mirjam Wild
Short-term outcomes of tricuspid edge-to-edge repair in clinical practice – bRIGHT study

Emerging options for patients with tricuspid regurgitation: a case-based discussion

19 May 2023 – From EuroPCR 2023

Want to view or revisit the key messages shared during this session on innovations in tricuspid regurgitation? Consult the slides of the topos presented by the speakers and discover what's essential to remember about the different entities of regurgitation, the potential and limitations of TTVR, patient...

Tricuspid regurgitation

EuroPCR 2023 Highlights: Interventions for Valvular Disease

20 May 2023 – From EuroPCR 2023

Nicolas Dumonteil and Bernard Prendergast join Christopher Cook in the PCR recording studio to talk about their personal highlights from another fantastic edition of EuroPCR. From the simulation programme - a key activity of PCR Courses - to the traditional learning sessions by and for the...

EuroPCR 2023 Highlights on interventions for valvular disease

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

17 May 2023 – From EuroPCR 2023

Listen to Nicole Karam and Fabien Praz talk about the latest update from the TRILUMINATE study, the very first randomized trial conducted to determine how to improve the prognosis of tricuspid regurgitation.

To do so, the study aimed at comparing optimal medical treatment with interventions with edge-to-edge repair.

The content...

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

Tricuspid and pulmonary valves: the right heart in trouble

18 May 2023 – From EuroPCR 2023

Explore the intricacies of tricuspid and pulmonary valve disorders, as we delve into the challenges faced by the right heart in this session: discover the groundbreaking approach of triple percutaneous valvular therapy in patient with congenital heart disease, learn about innovative strategies for managing massive atrial...

Tricuspid and pulmonary valves: the right heart in trouble

Pivotal momentum for tricuspid valve interventions (Episode 1: the right side)

18 May 2023 – From EuroPCR 2023

Based on an in-depth review of the data from TRILUMINATE pivotal, a randomized trial whose findings were recently published in the NEW ENGLAND JOURNAL of MEDICINE, this lecture explains how these results will impact clinical practice in the treatment of tricuspid regurgitation. Join the speakers and...

Pivotal momentum for

Valvular heart disease: novel transcatheter approaches

18 May 2023 – From EuroPCR 2023

Explore this thrilling session on transcatheter approaches for valvular heart disease, featuring the latest advancements, emerging techniques, and revolutionary research. Join your peer as they present novel strategies and devices aimed at improving valvular disease management.

Valvular heart disease: novel transcatheter approaches

Heterotopic valve replacement for patients with right heart failure and tricuspid regurgitation - All you need to know!

17 May 2023 – From EuroPCR 2023

Discover the comprehensive guide to heterotopic valve replacement for patients experiencing right heart failure and tricuspid regurgitation. Join this session to gain insights into patient selection criteria, delve into the concept behind this innovative procedure, and grasp the fundamental aspects of its execution.

Heterotopic valve replacement

EuroPCR 2023 Hotlines/Late-Breaking Trials: mitral and tricuspid valves disease

17 May 2023 – From EuroPCR 2023

The presenters share their views on a range of essays and studies. Join them for an update on: Early experience with a d-shape, monoleaflet TMVR system; Outcomes of Mitral Valve-in-Valve, Mitral Valve-in-Ring and Valve-in-Mitral Annular; Calcification: prospective MITRAL; DRAGONFLY-DMR: transcatheter repair by DragonFly device in mitral...